— Know what they know.
Not Investment Advice
Also trades as: TH.TO (TSX) · $vol 0M

THTX NASDAQ

Theratechnologies Inc.
1W: +0.0% 1M: +4.6% 3M: +5.9% 1Y: +173.4% 3Y: -63.9% 5Y: -61.8%
$3.39
Last traded 2025-10-02 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $155.9M mcap · 38M float · 1.12% daily turnover · Short 36% of daily vol

Balance Sheet Trends

Total Assets
$53M -31.4% ▼
5Y CAGR: -14.6%
Total Liabilities
$79M -20.3% ▼
5Y CAGR: -3.2%
Shareholders Equity
-$25M -21.1% ▼
Cash & Investments
$10M -76.4% ▼
5Y CAGR: -25.0%
Total Debt
$46M -22.7% ▼
5Y CAGR: -2.1%
Net Debt
$40M +59.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$13M$20M$24M$34M$6M
Short-Term Investments$8M$20M$9M$6M$4M
Cash & ST Investments$21M$40M$33M$41M$10M
Net Receivables$11M$9M$11M$14M$16M
Inventory$25M$29M$20M$6M$5M
Other Current Assets$3M$2M$2M$892K$11M
Total Current Assets$65M$92M$73M$63M$44M
Property, Plant & Equip.$3M$3M$3M$2M$1M
Goodwill & Intangibles$32M$24M$15M$12M$8M
Long-Term Investments$0$0$0$0$214K
Other Non-Current Assets-$35M$621K$2M$0$271K
Total Non-Current Assets$35M$27M$20M$14M$9M
Total Assets$100M$119M$93M$78M$53M
— Liabilities —
Accounts Payable$18M$16M$13M$7M$6M
Short-Term Debt$0$0$65M$7M$3M
Deferred Revenue$50K$54K$38K$38K$38K
Other Current Liabilities$7M$4M$11M$13M$9M
Total Current Liabilities$42M$45M$114M$47M$37M
Long-Term Debt$52M$54M$0$51M$41M
Other Non-Current Liab.$41K$94K$106K$84K$21K
Total Non-Current Liabilities$55M$56M$2M$51M$42M
Total Liabilities$97M$101M$116M$99M$79M
— Equity —
Common Stock$287M$336M$339M$364M$364M
Retained Earnings-$300M-$335M-$383M-$409M-$417M
Accumulated OCI$4M$4M$385K$684K$898K
Total Stockholders Equity$3M$18M-$23M-$21M-$25M
Total Liabilities & Equity$100M$119M$93M$78M$53M
— Key Metrics —
Total Debt$55M$57M$67M$59M$46M
Net Debt$43M$36M$43M$25M$40M
Total Investments$8M$20M$9M$6M$4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms